Aim: To identify prognostic factors in patients with relapsing/refractory Hodgkin’s Disease treated with IGEV Chemotherapy and High Dose Consolidation Therapy.

Conclusions: Based on this analysis, a prognostic model for IGEV-treated patients with refractory/relapsed HD can be constructed using the above factors.

Official Title

Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue.


Study Type

Multivariate analysis

Study Design

Patients: 104 patients (pts) from several institutions with relapsed/refractory HD pt characteristics at accrual: M/ F 56/48, median age 31 (range 17-65) refractory / relapsed following last CT course 40/64, median previous CT regimens: 1 (range 1-2), symptoms A/ B 32/71, Hasenclever (IPS) score <3/ > 4: 72/24 (8 pts not evaluable), LDH ratio < 1/> 1: 68/35, Previous radiotherapy (RT) yes/no: 62/42.Treatment:4 induction cycles of IGEV ifosfamide 2000 mg/mq d 1-4; gemcitabine 800 mg/mq d 1& 4; vinorelbine 20 mg/mq d 1; prednisolone 100 mg/mq d 1-4, and G-CSF) and HDT consolidation.

Further Details

Results:Ater induction, 45 pts (43%) obtained complete remission (CR) 41 (40%) partial remission (PR) and 18 (17)% did not respond (NR). Overall 89 pts received HDT and at the end of the treatment program 76 out of 104 pts were in CR.On an intent-to treat analysis, two-year freedom from progression (FFP) & overall survival (OS) for the whole series were 47% and 74.6%, respectively.In univariate analysis FFP was negatively influenced by B symptoms, IPS score > 4, LDH ratio > 1, refractory disease, and by response to IGEV.

Study Start

Eligibility & Criteria

Indication: Hodgkin’s Disease

Total Enrolment

Contact Details

Monica Balzarotti, et al Abstract 2091 ASH 2005Multi-centre institution Italy

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.